Literature DB >> 21959094

[Ebrictus study. Functional results, survival, and potential years of life lost after the first stroke].

J L Clua-Espuny1, J L Piñol-Moreso, A Panisello-Tafalla, J Lucas-Noll, V F Gil-Guillen, D Orozco-Beltran, M L Queralt-Tomas.   

Abstract

AIM: To determine the mortality, degree of dependence, survival, and years of life lost (YLL) after first episode of stroke.
DESIGN: Cohort study. LOCATION: Community based register. PARTICIPANTS: A total of 553 subjects between 15-90 years with a first episode of definitive or transitory stroke were recruited between 01/04/2006 and 31/03/2008. MEASUREMENTS: The analyses were performed with the use of time-to-event methods, according to the intention-to-treat principle. The level of dependency was assessed according to the Barthel Scale one year after stroke; YLL (1-70 years) from the mean life expectancies at birth; survival analysis by Kaplan-Meier's curves, bivariate analysis comparing the variables between patients who had survived and those who died, and Cox's multivariate.
RESULTS: The mean age was 73.3 (±11.6 years. The mean time of follow-up was 29.7 ± 13,4 months, during which 26.6% of the patients died. The mean Barthel score fell by >20%, particularly among women. There was moderate or greater dependence in 41.5% (95%CI 30.6-52.8%) of the subjects. The overall accumulative probability of survival was 0.96 (95% CI 0.94-0.97) in the first month and 0.69 (95% CI 0.65-0.72) in the fourth year. The thrombolytic treatment showed a protective effect on mortality, particularly among the women. The main predictive variables were, history of recurrent cardiovascular event (RR 6.7, 95% CI 2.2-21.7) and aging (RR 1.08, 95% CI 1.01-1.2). The average YLL was 11.5/10000/year SD7.2, and higher among men.
CONCLUSION: There are differences in functional outcome, mortality, and potential years of life lost by gender. A new cardiovascular event is an independent prognostic factor of survival.
Copyright © 2011 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21959094      PMCID: PMC7025231          DOI: 10.1016/j.aprim.2011.04.004

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  17 in total

1.  [Epidemiology of cerebrovascular disease].

Authors:  J Matías-Guiu
Journal:  Rev Esp Cardiol       Date:  2000-01       Impact factor: 4.753

2.  Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With the Guidelines-Stroke Program.

Authors:  Eric E Smith; Nandavar Shobha; David Dai; Daiwai M Olson; Mathew J Reeves; Jeffrey L Saver; Adrian F Hernandez; Eric D Peterson; Gregg C Fonarow; Lee H Schwamm
Journal:  Circulation       Date:  2010-09-27       Impact factor: 29.690

3.  Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling.

Authors:  S Claiborne Johnston; Shanthi Mendis; Colin D Mathers
Journal:  Lancet Neurol       Date:  2009-02-21       Impact factor: 44.182

Review 4.  Acute neurological stroke care in Europe: results of the European Stroke Care Inventory.

Authors:  M Brainin; N Bornstein; G Boysen; V Demarin
Journal:  Eur J Neurol       Date:  2000-01       Impact factor: 6.089

Review 5.  Geographical and secular trends in stroke incidence.

Authors:  R Malmgren; C Warlow; J Bamford; P Sandercock
Journal:  Lancet       Date:  1987-11-21       Impact factor: 79.321

6.  Variations between countries in outcome after stroke in the International Stroke Trial (IST).

Authors:  N U Weir; P A Sandercock; S C Lewis; D F Signorini; C P Warlow
Journal:  Stroke       Date:  2001-06       Impact factor: 7.914

7.  [Cerebrovascular mortality in Spain].

Authors:  M T Olalla; M J Medrano; M J Sierra; J Almazán
Journal:  Rev Neurol       Date:  1999 Nov 1-15       Impact factor: 0.870

8.  [Comparison between several standard populations for age-adjusting].

Authors:  J Llorca Díaz; D Prieto Salceda; T Dierssen Sotos; M Delgado-Rodríguez
Journal:  Rev Esp Salud Publica       Date:  2000 Jul-Aug

Review 9.  Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis.

Authors:  Sarah T Pendlebury; Peter M Rothwell
Journal:  Lancet Neurol       Date:  2009-09-24       Impact factor: 44.182

10.  Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials.

Authors:  Inke R König; Andreas Ziegler; Erich Bluhmki; Werner Hacke; Philip M W Bath; Ralph L Sacco; Hans C Diener; Christian Weimar
Journal:  Stroke       Date:  2008-04-10       Impact factor: 7.914

View more
  4 in total

1.  Risk of Atrial Fibrillation, Ischemic Stroke and Cognitive Impairment: Study of a Population Cohort ≥65 Years of Age.

Authors:  Jose-Luis Clua-Espuny; Eulalia Muria-Subirats; Juan Ballesta-Ors; Blanca Lorman-Carbo; Josep Clua-Queralt; Elena Palà; Iñigo Lechuga-Duran; Delicia Gentille-Lorente; Alejandro Bustamante; Miguel Ángel Muñoz; Joan Montaner
Journal:  Vasc Health Risk Manag       Date:  2020-10-28

2.  Long-Term Survival After Stroke According to Reperfusion Therapy, Cardiovascular Therapy and Gender.

Authors:  Jose Luis Clua-Espuny; Sonia Abilleira; Lluisa Queralt-Tomas; Antonia Gonzalez-Henares; Vicente Gil-Guillen; Eulalia Muria-Subirats; Juan Ballesta-Ors
Journal:  Cardiol Res       Date:  2019-04-11

3.  [Differences in the survival after an episode of stroke treated with thrombolytic therapy. Study Ebrictus].

Authors:  Jose Luis Clua-Espuny; Rosa Ripolles-Vicente; Carlos Lopez-Pablo; Anna Panisello-Tafalla; Jorgina Lucas-Noll; Cristina Calduch-Noll; M Antonia González-Henares; M Lluisa Queralt-Tomas
Journal:  Aten Primaria       Date:  2014-06-19       Impact factor: 1.137

4.  Sex Differences in Long-Term Survival after a First Stroke with Intravenous Thrombolysis: Ebrictus Study.

Authors:  José Luis Clua-Espuny; Rosa Ripolles-Vicente; Teresa Forcadell-Arenas; Vicente Francisco Gil-Guillen; Maria Lluïsa Queralt-Tomas; María Antonia González-Henares; Anna Panisello-Tafalla; Carlos López-Pablo; Jorgina Lucas-Noll
Journal:  Cerebrovasc Dis Extra       Date:  2015-10-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.